BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2023 10:42:35 AM | Browse: 36 | Download: 18
Publication Name World Journal of Experimental Medicine
Manuscript ID 85135
Country/Territory Iraq
2023-04-13 09:12
Peer-Review Started
2023-04-13 09:15
To Make the First Decision
Return for Revision
2023-07-04 08:24
2023-07-05 22:51
Second Decision
2023-07-21 02:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-07-24 00:54
Articles in Press
2023-07-24 00:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-09-11 13:26
Publish the Manuscript Online
2023-09-15 10:42
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Critical Care Medicine
Manuscript Type Letter to the Editor
Article Title Update on hydroxychloroquine use in pregnancy
Manuscript Source Unsolicited Manuscript
All Author List Wassan Nori, Nabeeha Najatee Akram and Raid M Al-Ani
Author(s) ORCID Number
Wassan Nori http://orcid.org/0000-0002-8749-2444
Nabeeha Najatee Akram http://orcid.org/0000-0001-8964-8943
Raid M Al-Ani http://orcid.org/0000-0003-4263-9630
Funding Agency and Grant Number
Corresponding Author Wassan Nori, PhD, Academic Editor, Academic Research, Senior Researcher, Department of Obstetrics and Gynecology, Mustansiriyah University, No. 58 Al-amin Street, Baghdad 10052, Iraq. dr.wassan76@uomustansiriyah.edu.iq
Key Words Pregnancy; Hydroxychloroquine; Preeclampsia; Antiphospholipid syndrome; Chronic placental inflammation; COVID-19
Core Tip The immunomodulatory, anti-inflammatory, and anti-thrombotic activity of hydroxychloroquine (HCQ), an anti-malarial drug, made it recommendable for rheumatoid arthritis and systemic lupus erythematosus. HCQ was also implemented in refractory antiphospholipid syndrome showing a successful outcome. Recent evidence supports the benefits of its use to outweigh the risk during pregnancy as it reduces the disease activity and the associated adverse pregnancy outcome. Chronic placental inflammation is another condition for which HCQ proved to be helpful. Further investigations are required to verify HCQ’s efficacy in chronic placental inflammation as well as its action in reducing the severity of coronavirus disease 2019 in pregnant women.
Publish Date 2023-09-15 10:42
Citation Nori W, Akram NN, Al-Ani RM. Update on hydroxychloroquine use in pregnancy. World J Exp Med 2023; 13(4): 99-101
URL https://www.wjgnet.com/2220-315x/full/v13/i4/99.htm
DOI https://dx.doi.org/10.5493/wjem.v13.i4.99
Full Article (PDF) WJEM-13-99-with-cover.pdf
Full Article (Word) WJEM-13-99.docx
Manuscript File 85135_Auto_Edited-JLW.docx
Answering Reviewers 85135-Answering reviewers.pdf
Audio Core Tip 85135-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 85135-Conflict-of-interest statement.pdf
Copyright License Agreement 85135-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 85135-Language certificate.pdf
Peer-review Report 85135-Peer-review(s).pdf
Scientific Misconduct Check 85135-Bing-Qu XL-2.png
Scientific Editor Work List 85135-Scientific editor work list.pdf